Nicholas Ferenc

Nicholas Ferenc is an experienced professional in the oncology sector, currently serving as Global Project Leader in R&D at Takeda Oncology since 2020, and previously holding the position of Senior Director in Portfolio Management and External Innovation at Takeda Pharmaceuticals since January 2014. With a robust background in personalized medicine and companion diagnostics strategy at Sanofi, Nicholas developed critical functions within the oncology division, overseeing CDx strategy and development. Additional accomplishments include leading global marketing efforts for Thymoglobulin, achieving significant sales growth, and holding various strategic roles at companies such as Wyeth and AstraZeneca. Nicholas holds a Master of Science in Molecular Biology/Biotechnology and an MBA from The Johns Hopkins University, in addition to a BS in Chemistry from Wake Forest University.